Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 23, 2017 07:00 ET | Source: ParkerVision, Inc.

German Court Decision in ParkerVision v. Apple Infringement Case Awaits Validity Ruling

JACKSONVILLE, Fla., June 23, 2017 (GLOBE NEWSWIRE) -- ParkerVision, Inc. (NASDAQ:PRKR), announced today that the Regional Court of Munich is holding its decision in the ParkerVision v. Apple case...
June 23, 2017 07:00 ET | Source: uniQure N.V.

uniQure Announces Clinical Data Presentations at the Upcoming International Society on Thrombosis and Hemostasis (ISTH) Congress

LEXINGTON, Mass. and AMSTERDAM, the Netherlands, June 23, 2017 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ:QURE), a leading gene therapy company advancing transformative therapies for patients with...
June 23, 2017 07:00 ET | Source: Repligen Corporation

Repligen Corporation and Spectrum, Inc. to Join Forces

- Adds to Repligen a leader in bioprocess filtration with expertise in hollow fiber technology- Strengthens flagship XCell™ ATF product line with an extensive filtration consumables portfolio-...
June 23, 2017 07:00 ET | Source: Sunesis Pharmaceuticals Inc

Sunesis Pharmaceuticals Announces Presentation of Updated Results from Washington University-Sponsored Phase 1/Cohort Expansion Trial of Vosaroxin Plus Azacitidine in Patients with MDS at the EHA Annual Meeting

SOUTH SAN FRANCISCO, Calif., June 23, 2017 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq:SNSS) today announced the presentation of updated results from a Washington University-sponsored...
June 23, 2017 07:00 ET | Source: Proteostasis Therapeutics, Inc

Proteostasis Therapeutics Files Investigational New Drug Application for PTI-808, Cystic Fibrosis Potentiator

CAMBRIDGE, Mass., June 23, 2017 (GLOBE NEWSWIRE) -- Proteostasis Therapeutics, Inc. (NASDAQ:PTI), a biopharmaceutical company developing small molecule therapeutics to treat diseases caused by...
June 23, 2017 07:00 ET | Source: NewLink Genetics Corporation

Positive Phase 1b Data for NewLink Genetics’ IDO Pathway Inhibitor, Indoximod, in Combination with Chemotherapy for Patients with Newly Diagnosed Acute Myeloid Leukemia (AML) Presented at the European Hematologic Association (EHA) Congress in Madrid, Spain

AMES, Iowa, June 23, 2017 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (NASDAQ:NLNK) today announced the presentation of data from the Phase 1b portion of a study of indoximod, an IDO pathway...
June 23, 2017 07:00 ET | Source: Cara Therapeutics Inc.

Cara Receives Breakthrough Therapy Designation from FDA for I.V. CR845 for the Treatment of Chronic Kidney Disease-Associated Pruritus in Hemodialysis Patients

STAMFORD, Conn., June 23, 2017 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq:CARA), a biopharmaceutical company focused on developing and commercializing new chemical entities designed to...
June 23, 2017 07:00 ET | Source: Bellicum Pharmaceuticals

Bellicum Reports Clinical Results of BPX-501 in Pediatric Leukemias at the 22nd Congress of the European Hematology Association

MADRID, Spain, June 23, 2017 (GLOBE NEWSWIRE) -- Bellicum Pharmaceuticals, Inc. (Nasdaq:BLCM), a leader in developing novel, controllable cellular immunotherapies for cancers and orphan inherited...
June 23, 2017 07:00 ET | Source: Alcobra Ltd.

Alcobra Updates on its Review of Strategic Alternatives

TEL AVIV, Israel, June 23, 2017 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD), an emerging pharmaceutical company focused on the development of new medications to treat significant unmet clinical...
June 23, 2017 07:00 ET | Source: Bellicum Pharmaceuticals

Bellicum Announces Clinical Data on BPX-501 at Presidential Symposium of the 22nd Congress of the European Hematology Association

MADRID, Spain, June 23, 2017 (GLOBE NEWSWIRE) -- Bellicum Pharmaceuticals, Inc. (Nasdaq:BLCM), a leader in developing novel, controllable cellular immunotherapies for cancers and orphan inherited...

1 ...178715 178716 178717 ...326066